Clinical Trials Directory

Trials / Recruiting

RecruitingNCT07165938

Genetics of Neonatal Encephalopathy and Related Disorders

Status
Recruiting
Phase
Study type
Observational
Enrollment
300 (estimated)
Sponsor
Boston Children's Hospital · Academic / Other
Sex
All
Age
Healthy volunteers
Not accepted

Summary

Investigators at Boston Children's Hospital are conducting research in order to better understand the genetic factors which may contribute to neonatal encephalopathy (NE) and related disorders. These findings may help explain the broad spectrum of clinical features and outcomes seen in individuals with a history of NE.

Detailed description

Neonatal encephalopathy (NE) is a disorder of term newborns involving dysfunction of the central nervous system and can impact one's health throughout the lifespan. While NE can be caused by a number of exposures or external factors, in some cases there is no cause identified or the severity of the condition cannot fully be explained by external factors. In these cases, there is increasing evidence to suggest underlying genetic factors may contribute to NE. The investigators' research effort is focused on identifying genetic changes (known as "DNA variants") that cause or contribute to NE. By doing so the investigators hope to improve diagnosis and management of NE. We have two specific aims: Aim 1: To identify genetic causes of and contributors to NE and related disorders. Aim 2: To correlate genetic findings with clinical features.

Conditions

Timeline

Start date
2026-02-04
Primary completion
2035-09-01
Completion
2035-09-01
First posted
2025-09-10
Last updated
2026-03-11

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT07165938. Inclusion in this directory is not an endorsement.